TSS
NUVB icon

Two Sigma Securities’s Nuvation Bio NUVB Stock Holding History

Two Sigma Securities’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$109K Buy
+25,442
New +$142K 0.01% 1159
2025
Q4 		– Sell
-22,565
Closed -$83.5K – 1849
2025
Q3 		$83.5K Buy
+22,565
New +$61.5K 0.01% 930

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DFO
Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Two Sigma Securities's NUVB Position: Q1 2026 in Review

Two Sigma Securities opened a new position in Nuvation Bio (NUVB) in Q1 2026: 25,442 shares worth $109K. The stake represents 0.01% of the portfolio and ranks #1159 among its holdings. This is a return to the name: Two Sigma Securities previously reported a position in NUVB as recently as Q3 2025.

Two Sigma Securities first reported a position in NUVB in Q3 2025 and has held it in 2 quarters since. 231 funds tracked by Wall St. Rank hold NUVB as of Q1 2026.

  • Two Sigma Securities held 25,442 shares of Nuvation Bio worth $109K as of Q1 2026.
  • Nuvation Bio was a new Two Sigma Securities position in Q1 2026.
  • Nuvation Bio made up 0.01% of Two Sigma Securities's portfolio in Q1 2026, its #1159 holding.
  • Two Sigma Securities first reported a position in Nuvation Bio in Q3 2025 and has held it in 2 quarters since.
  • 231 funds tracked by Wall St. Rank held Nuvation Bio as of Q1 2026.

Based on Two Sigma Securities's 13F filing for Q1 2026, filed 15 May 2026.